Rizzuti, Mafalda
Melzi, Valentina
Gagliardi, Delia
Resnati, Davide
Meneri, Megi
Dioni, Laura
Masrori, Pegah
Hersmus, Nicole
Poesen, Koen
Locatelli, Martina
Biella, Fabio
Silipigni, Rosamaria
Bollati, Valentina
Bresolin, Nereo
Comi, Giacomo Pietro
Van Damme, Philip
Nizzardo, Monica
Corti, Stefania http://orcid.org/0000-0001-5734-7476
Funding for this research was provided by:
Fondazione Italiana di Ricerca per la SLA, AriSLA (smallRNALS)
Fondazione Regionale per la Ricerca Biomedica, FRRB (TransALS)
Italian Ministry of Health (Ricerca Corrente 2020 RC245)
E-Rare3 JTC2018 (Integrals)
Italian Ministry of Health (RF-2013-02355764)
The E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders (senior clinical investigatorship of FWO-Vlaanderen)
ALS Liga België
Een Hart voor ALS
Laeversfonds voor ALS Onderzoek
Valéry Perrier Race against ALS Fund
Article History
Received: 5 November 2021
Revised: 18 February 2022
Accepted: 21 February 2022
First Online: 14 March 2022
Change Date: 30 July 2022
Change Type: Update
Change Details: Missing Open Access funding information has been added in the Funding Note.
Declarations
:
: The authors report no competing interests.
: The studies involving human samples were conducted in accordance with the ethical standards of the Declaration of Helsinki and with national legislation and institutional guidelines. Human fibroblast cell lines were obtained from Eurobiobank with informed consent approved by the ethical committee at Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan. All subjects provided written informed consent approved by the local ethical committee for the collection, storage and analysis of CSF samples (0,004,520, S50354, S55312, S59552). This experimental study was conducted in accordance with the international GLP and GCP guidelines.
: Not applicable.